InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Subramanian Sanjay, Chief Financial Officer. Officer active across 2 companies, notably Ocugen, Inc.. Aggregated, 17 filings have been recorded. Total volume traded: €284k. The latest transaction was filed on 19 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations17 total
€92,63927,100 shares@ €3.4184100.0% of flow
Common Stock
SEC:0001209191-22-024916:0·
Ideal exit: 14 Jan 2023 (T+270)
0125,534 shares0
Common Stock
SEC:0001062993-22-000700·
0125,534 shares0
Common Stock
SEC:0001062993-22-000700:0·
€95,44610,000 shares@ €9.54460.023% mcap59.7% of flow
Common Stock
SEC:0001879785-21-000013·
€95,44610,000 shares@ €9.54460.023% mcap29.8% of flow
Common Stock
SEC:0001879785-21-000013:0·
€15,0967,990 shares@ €1.88930.0036% mcap9.4% of flow
Common Stock
SEC:0001192482-21-000740·
€15,0967,990 shares@ €1.88930.0036% mcap4.7% of flow
Common Stock
SEC:0001192482-21-000740:0·
€8,65930,000 shares@ €0.28860.0021% mcap5.4% of flow
Common Stock
SEC:0001192482-21-000669·
€8,65930,000 shares@ €0.28860.0021% mcap2.7% of flow
Common Stock
SEC:0001192482-21-000669:0·
€8,94831,086 shares@ €0.28780.0021% mcap5.6% of flow
Common Stock
SEC:0001192482-21-000633·
€8,94831,086 shares@ €0.28780.0021% mcap2.8% of flow
Common Stock
SEC:0001192482-21-000633:0·
€8,69131,000 shares@ €0.28040.0021% mcap5.4% of flow
Common Stock
SEC:0001790246-21-000003·
€8,69131,000 shares@ €0.28040.0021% mcap2.7% of flow
Common Stock
SEC:0001790246-21-000003:0·
€8,72731,000 shares@ €0.28150.0021% mcap5.5% of flow
Common Stock
SEC:0001192482-21-000423·
€8,72731,000 shares@ €0.28150.0021% mcap2.7% of flow
Common Stock
SEC:0001192482-21-000423:0·
€14,4297,990 shares@ €1.80590.0034% mcap9.0% of flow
Common Stock
SEC:0001192482-21-000394·
€14,4297,990 shares@ €1.80590.0034% mcap4.5% of flow
Common Stock
SEC:0001192482-21-000394:0·
17 of 17 declarations
About Subramanian Sanjay
Subramanian Sanjay is an executive at Ocugen, Inc.
